Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Mitchell Collision Repair Industry Data: Q4 2017
Appraisal Values The initial average appraisal value, calculated by combining data from all first and third-party repairable vehicle appr
Mitchell
Article
Canadian Collision Summary: Q4 2017
Canadian Appraisal Severity Average Appraisal Values Severity Overall The average gross initial appraisal value, calculated by
Workers' Comp
Podcast
Empowering Injured Workers
Mitchell
Article
Insurers Lead in AI Investment
Where Are They Investing and Why? In a recent stud
Workers' Comp
News Release
Risk & Insurance: Protecting Data in Motion
Multiple points of exposure within the workers' compensation industry make it challenging to ensure the security of patient information.
Workers' Comp
Article
New Workers' Compensation Review Contractor
Keep current with new legislation and its potential effect on your organization.